VVX · XBRL financial data
V2X financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (VVX's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 1,396 | 1,784 | 2,891 | 3,963 | 4,322 | 4,480 |
| Cost of goods and services sold | 1,271 | 1,623 | 2,596 | 3,628 | 3,979 | 4,107 |
| Selling, general and administrative | 81 | 98 | 239 | 210 | 184 | 179 |
| Other operating income (expense) | — | 0 | 0 | (4) | (10) | (11) |
| Operating income (loss) | 43 | 62 | 56 | 124 | 159 | 194 |
| Income tax expense (benefit) | 2 | 8 | 8 | (2) | 4 | 23 |
| Net income (loss) | 37 | 46 | (14) | (23) | 35 | 78 |
| Earnings per share, basic USD per share | 3.19 | 3.91 | (0.68) | (0.73) | 1.10 | 2.47 |
| Earnings per share, diluted USD per share | 3.14 | 3.86 | (0.68) | (0.73) | 1.08 | 2.45 |
| Weighted average shares, basic millions of shares | 12 | 12 | 21 | 31 | 31 | 32 |
| Weighted average shares, diluted millions of shares | 12 | 12 | 21 | 31 | 32 | 32 |
Balance sheet
CSVFiscal years (VVX's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 67 | 39 | 116 | 73 | 268 | 369 |
| Inventory | — | — | 45 | 47 | 51 | 46 |
| Prepaid and other current assets | — | — | 42 | 49 | 71 | 127 |
| Total current assets | 408 | 423 | 932 | 875 | 1,100 | 1,235 |
| Property and equipment, net | 23 | 24 | 79 | 85 | 62 | 52 |
| Right-of-use asset | 19 | 44 | 53 | 41 | 38 | 29 |
| Goodwill | 340 | 322 | 1,654 | 1,657 | 1,657 | 1,677 |
| Total assets | 844 | 889 | 3,233 | 3,082 | 3,229 | 3,281 |
| Accounts payable | 160 | 213 | 407 | 453 | 548 | 557 |
| Accrued liabilities | 41 | 55 | 197 | 214 | 262 | 267 |
| Current portion of long-term debt | 9 | 10 | 12 | 15 | 20 | 15 |
| Total current liabilities | 288 | 358 | 783 | 840 | 996 | 1,016 |
| Long-term debt | 169 | 94 | 1,263 | 1,100 | 1,087 | 1,083 |
| Lease liability, non-current | 14 | 35 | 41 | 35 | 34 | 30 |
| Total liabilities | 539 | 539 | 2,236 | 2,091 | 2,203 | 2,196 |
| Retained earnings | 222 | 268 | 253 | 231 | 266 | 343 |
| Total stockholders' equity | 305 | 350 | 997 | 991 | 1,026 | 1,085 |
| Total liabilities and equity | 844 | 889 | 3,233 | 3,082 | 3,229 | 3,281 |
| Common shares outstanding (cover page) millions of shares | 12 | 12 | 31 | 31 | 32 | 31 |
Cash flows
CSVFiscal years (VVX's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | 37 | 46 | (14) | (23) | 35 | 78 |
| Stock-based compensation | 9 | 8 | 33 | 33 | 16 | 12 |
| Net cash from operating activities | 64 | 61 | 93 | 188 | 254 | 182 |
| Net cash from investing activities | (138) | (13) | 176 | (23) | (29) | (30) |
| Share repurchases | — | — | — | 0 | 0 | 30 |
| Proceeds from long-term debt | — | 0 | 0 | 250 | 0 | 0 |
| Repayments of long-term debt | 7 | 9 | 108 | 433 | 15 | 15 |
| Net cash from financing activities | 106 | (76) | (193) | (211) | (24) | (51) |
| Net change in cash | 33 | (30) | 78 | (43) | 196 | 101 |
Compare with peers
SIC 8744 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8744 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| V2X | 265 | 1,271 | 67* | 31.4M | — | 10-QOct 2, 2026 |
| Onterris | 13 | 187 | 6.2* | 35.1M | — | 10-QJun 30, 2026 |
| TSS | 68 | 35 | 7.6* | 28.2M | — | 10-Q/AJun 30, 2026 |
| Astrana Health | 401 | 973 | 33* | 55.7M | — | 10-QJun 30, 2026 |
| Hackett Group | 14 | 69 | 15* | 24.9M | — | 10-QJun 26, 2026 |
| Bowman Consulting Group | 10 | 146 | (7.9)* | 17.3M | 1.3 quarters | 10-QJun 30, 2026 |
| Evolent Health | 116 | 653 | (9.3)* | 113.1M | 12.4 quarters | 10-QJun 30, 2026 |
| Franklin Covey | 12 | 68 | 1.1* | 11.3M | — | 10-QMay 31, 2026 |
| ICF International | 4.6 | 474 | 100* | 17.9M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.